Method for reducing circulating leukocytes in a human subject
Abstract:
The present disclosure relates to a method for treatment or prevention of diseases have an increased level of insulin-like growth factor I (IGF-I). The method comprises administration of a growth hormone (GH) variant having antagonistic activity in combination with an oligonucleotide targeted to growth hormone receptor (GHR) to a subject in need.
Public/Granted literature
Information query
Patent Agency Ranking
0/0